Levetiracetam Tablet, Film Coated
Product Images NDC 50090-7333

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-7333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This text provides information on the percentage values and sample sizes for different groups involved in a study. It includes percentages such as 45%, 37.1%, and 74% related to Placebo, Levetiracetam Tablet, and their different dosages. The study involved a group of 85 participants for Placebo, 97 participants for Levetiracetam Tablet with 1000 mg/day, and 101 participants for Levetiracetam Tablet with 3000 mg/day.*

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

This text provides information about the percentage of patients in a study under different treatments. It includes data for placebo (N=104) and tamoxifen 3000 mg/day (N=150).*

FDA Label Image

Figure4 (Figure4)

This passage provides statistics related to different percentages. The text mentions percentages such as 45%, 196%, and 446%, and then mentions the number of participants in two groups labeled as Placebo (N=97) and Levetiracetam Tablet (N=101). This information appears to be part of a study or statistical analysis.*

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Label Image (Lbl500907333)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.